Default: Journal of Cachexia, Sarcopenia and Muscle

ISSN: 2190-5991

Journal Home

Journal Guideline

Journal of Cachexia, Sarcopenia and Muscle Q1 Unclaimed

Wiley-Blackwell United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Cachexia, Sarcopenia and Muscle is a journal indexed in SJR in Physiology (medical) and Orthopedics and Sports Medicine with an H index of 66. It is an CC BY-NC-ND Journal with a Single blind Peer Review review system, and It has a price of 2250 €. The scope of the journal is focused on cachexia, sarcopenia, muscle, muscle wasting, wasting syndromes, body composition. It has an SJR impact factor of 2,803 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,803.

Type: Journal

Type of Copyright: CC BY-NC-ND

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Price

2250 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Journal of Cachexia, Sarcopenia and Muscle

2,803

SJR Impact factor

66

H Index

150

Total Docs (Last Year)

316

Total Docs (3 years)

8380

Total Refs

3189

Total Cites (3 years)

276

Citable Docs (3 years)

9,55

Cites/Doc (2 years)

55,87

Ref/Doc

Aims and Scope


Cachexia Sarcopenia Muscle Muscle wasting Wasting syndromes Body composition



Best articles by citations

A systematic review on the role of vitamins, minerals, proteins, and other supplements for the treatment of cachexia in cancer: a European Palliative Care Research Centre cachexia project

View more

Muscle mass measures and incident osteoporosis in a large cohort of postmenopausal women

View more

Preoperative sarcopenia and post-operative accelerated muscle loss negatively impact survival after resection of pancreatic cancer

View more

Psoas

View more

Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis

View more

Psoas muscle fluorine-18-labelled fluoro-2-deoxy-d-glucose uptake associated with the incidence of existing and incipient metabolic derangement

View more

Prevalence of sarcopenia among community-dwelling elderly of a medium-sized South American city: results of theCOMO VAI? study

View more

Assessing sarcopenic prevalence and risk factors in residential aged care: methodology and feasibility

View more

Increased desmin expression in hindlimb muscles of aging rats

View more

Muscle radiodensity loss during cancer therapy is predictive for poor survival in advanced endometrial cancer

View more

Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?!

View more

Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia

View more
SHOW MORE ARTICLES

Silver linings on the horizon: highlights from the 10th Cachexia Conference

View more

Exercise restores muscle stem cell mobilization, regenerative capacity and muscle metabolic alterations via adiponectin/AdipoR1 activation in SAMP10 mice

View more

Computed tomography diagnosed cachexia and sarcopenia in 725 oncology patients: is nutritional screening capturing hidden malnutrition?

View more

Sirtuin 1 in skeletal muscle of cachectic tumour-bearing rats: a role in impaired regeneration?

View more

Trimetazidine restores the positive adaptation to exercise training by mitigating statin-induced skeletal muscle injury

View more

Sources for skeletal muscle repair: from satellite cells to reprogramming

View more

Febuxostat improves outcome in a rat model of cancer cachexia

View more

The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia

View more

Erratum to: Assessing sarcopenic prevalence and risk factors in residential aged care: methodology and feasibility

View more

Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia

View more

Degenerin channel activation causes caspase-mediated protein degradation and mitochondrial dysfunction in adultC.elegansmuscle

View more

Tumour-specific and organ-specific protein synthesis rates in patients with pancreatic cancer

View more

Comments

No comments ... Be the first to comment!

FAQS